These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 34561352)

  • 1. First-line Medications for the Outpatient Treatment of Alcohol Use Disorder: A Systematic Review of Perceived Barriers.
    Gregory C; Chorny Y; McLeod SL; Mohindra R
    J Addict Med; 2022 Jul-Aug 01; 16(4):e210-e218. PubMed ID: 34561352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Barriers to and Facilitators of Alcohol Use Disorder Pharmacotherapy in Primary Care: A Qualitative Study in Five VA Clinics.
    Williams EC; Achtmeyer CE; Young JP; Berger D; Curran G; Bradley KA; Richards J; Siegel MB; Ludman EJ; Lapham GT; Forehand M; Harris AHS
    J Gen Intern Med; 2018 Mar; 33(3):258-267. PubMed ID: 29086341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implementing alcohol use disorder pharmacotherapy in primary care settings: a qualitative analysis of provider-identified barriers and impact on implementation outcomes.
    Hagedorn HJ; Wisdom JP; Gerould H; Pinsker E; Brown R; Dawes M; Dieperink E; Myrick DH; Oliva EM; Wagner TH; Harris AHS
    Addict Sci Clin Pract; 2019 Jul; 14(1):24. PubMed ID: 31291996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integration of a clinical pharmacy specialist into a substance use disorder intensive outpatient treatment program to improve prescribing rates of alcohol use disorder pharmacotherapy.
    Dimitropoulos E; Bertucci S; Wong K
    Subst Abus; 2018; 39(2):190-192. PubMed ID: 29558338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategies to increase implementation of pharmacotherapy for alcohol use disorders: a structured review of care delivery and implementation interventions.
    Williams EC; Matson TE; Harris AHS
    Addict Sci Clin Pract; 2019 Feb; 14(1):6. PubMed ID: 30744686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Provider perspectives on emergency department initiation of medication assisted treatment for alcohol use disorder.
    Philippine T; Forsgren E; DeWitt C; Carter I; McCollough M; Taira BR
    BMC Health Serv Res; 2022 Apr; 22(1):456. PubMed ID: 35392901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Place of Pharmacotherapy in Alcohol Use Disorder Management in Family Practice - A Systematic Review.
    Morgane GL; Delphine LG; Guillaume K; Yves LJ
    Curr Pharm Des; 2021; 27(23):2737-2745. PubMed ID: 33059563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medication Utilization for Alcohol Use Disorder in a Commercially Insured Population.
    Huskamp HA; Reif S; Greenfield SF; Normand ST; Busch AB
    J Gen Intern Med; 2020 Nov; 35(11):3262-3270. PubMed ID: 32754780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Practice Habits, Knowledge, and Attitudes of Hepatologists to Alcohol Use Disorder Medication: Sobering Gaps and Opportunities.
    Cotter TG; Ayoub F; King AC; Reddy KG; Charlton M
    Transplant Direct; 2020 Oct; 6(10):e603. PubMed ID: 33134483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Impact of Mobile Apps on Alcohol Use Disorder: A Systematic Review Protocol.
    Sawares AS; Shen N; Xue Y; Abi-Jaoude A; Wiljer D
    JMIR Res Protoc; 2017 Apr; 6(4):e49. PubMed ID: 28377366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic reviews of the effectiveness of day care for people with severe mental disorders: (1) acute day hospital versus admission; (2) vocational rehabilitation; (3) day hospital versus outpatient care.
    Marshall M; Crowther R; Almaraz-Serrano A; Creed F; Sledge W; Kluiter H; Roberts C; Hill E; Wiersma D; Bond GR; Huxley P; Tyrer P
    Health Technol Assess; 2001; 5(21):1-75. PubMed ID: 11532238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in the Use of Naltrexone for Addiction Treatment among Alcohol Use Disorder Admissions in U.S. Substance Use Treatment Facilities.
    Qeadan F; Mensah NA; Gu LY; Madden EF; Venner KL; English K
    Int J Environ Res Public Health; 2021 Aug; 18(16):. PubMed ID: 34444639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of Gabapentin for the Treatment of Alcohol Use Disorder in Patients With Alcohol Withdrawal Symptoms: A Randomized Clinical Trial.
    Anton RF; Latham P; Voronin K; Book S; Hoffman M; Prisciandaro J; Bristol E
    JAMA Intern Med; 2020 May; 180(5):728-736. PubMed ID: 32150232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. National outpatient medication utilization for opioid and alcohol use disorders from 2014 to 2016.
    Evoy KE; Roccograndi L; Le S; Leonard CE; Covvey JR; Ochs L; Peckham AM; Soprano SE; Reveles KR
    J Subst Abuse Treat; 2020 Dec; 119():108141. PubMed ID: 33138926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological interventions for alcohol misuse in correctional settings: A systematic review.
    Slavin-Stewart C; Minhas M; Turna J; Brasch J; Olagunju AT; Chaimowitz G; MacKillop J
    Alcohol Clin Exp Res; 2022 Jan; 46(1):13-24. PubMed ID: 34825363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Service-level barriers to and facilitators of access to services for the treatment of alcohol use disorder and problematic alcohol use: protocol for a scoping review.
    Wolfe D; Hutton B; Corace K; Chaiyakunapruk N; Ngorsuraches S; Nochaiwong S; Presseau J; Grant A; Suschinsky K; Skidmore B; Bartram M; Cohen K; Garner G; DiGioacchino L; Pump A; Peters B; Konefal S; Porath A; Thavorn K
    BMJ Open; 2022 Nov; 12(11):e064578. PubMed ID: 36410826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicians' perspectives and perceived barriers to caring for patients with alcohol use disorder and cirrhosis.
    Johnson E; Ghosh SM; Daniels VJ; Wild TC; Tandon P; Hyde A
    Addict Sci Clin Pract; 2022 Feb; 17(1):9. PubMed ID: 35139919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence based models of care for the treatment of alcohol use disorder in primary health care settings: a systematic review.
    Rombouts SA; Conigrave JH; Saitz R; Louie E; Haber P; Morley KC
    BMC Fam Pract; 2020 Dec; 21(1):260. PubMed ID: 33278891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.